Skip to content

OptimizeRx OPRX Financing Cash Flow

Financing Cash Flow at other companies

Veeva Systems logo
Veeva SystemsVEEV
-$262.53M-1,388%
Phreesia logo
PhreesiaPHR
-$26.09M-3,014%
Doximity logo
DoximityDOCS
-$93.16M-214%
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
-$16.3M+84.5%
PubMatic logo
PubMaticPUBM
-$8.06M-80.2%
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
-$1K-100%

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's financing cash flow?
OptimizeRx (OPRX) reported financing cash flow of -$2.71M in Q1 2026.
How has OptimizeRx's financing cash flow changed year-over-year?
OptimizeRx's financing cash flow decreased by 361.3% year-over-year, from -$587K to -$2.71M.
What is the long-term trend for OptimizeRx's financing cash flow?
Over 4 years (2021 to 2025), OptimizeRx's financing cash flow has grown at a -41.3% compound annual growth rate (CAGR), from $73.92M to -$8.8M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.